The following are multiple choice questions (with answers) about medical knowledge.   **Question:** A 47-year-old woman with metastatic breast cancer who is undergoing chemotherapy comes to the physician for a follow-up exam. She reports extreme fatigue since beginning her chemotherapy regimen. Her pulse is 98/min, respirations are 16/min, and blood pressure is 132/84 mm Hg. Her hemoglobin is 10.4 g/dL, leukocyte count is 800/mm3 with 5% monocytes, and platelet count is 50,000/mm3. The patient is started on a new medication. One week later, serum studies show a hemoglobin of 10.6 g/dL, a leukocyte count of 2,000/mm3 with 2% monocytes, and a platelet count of 56,000/mm3. Which of the following drugs is the most likely cause of these findings?   (A) Aldesleukin   (B) Interferon beta   (C) Filgrastim   (D) Romiplostim
['(C) Filgrastim <> answer', 'The following are multiple choice questions (with answers) about medical knowledge. <> instruction', '(A) Aldesleukin \n (B) Interferon beta \n (C) Filgrastim \n (D) Romiplostim <> possible answers', '  A 47-year-old woman with metastatic breast cancer who is undergoing chemotherapy comes to the physician for a follow-up exam. She reports extreme fatigue since beginning her chemotherapy regimen. Her pulse is 98/min, respirations are 16/min, and blood pressure is 132/84 mm Hg. Her hemoglobin is 10.4 g/dL, leukocyte count is 800/mm3 with 5% monocytes, and platelet count is 50,000/mm3. The patient is started on a new medication. One week later, serum studies show a hemoglobin of 10.6 g/dL, a leukocyte count of 2,000/mm3 with 2% monocytes, and a platelet count of 56,000/mm3. Which of the following drugs is the most likely cause of these findings? <> context@']